Stempoint Capital’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.29M | Buy |
315,812
+114,912
| +57% | +$1.2M | 1.06% | 29 |
|
|
2025
Q1 | $2.27M | Hold |
200,900
| – | – | 0.72% | 34 |
|
|
2024
Q4 | $2.11M | Buy |
200,900
+900
| +0.5% | +$9.45K | 0.53% | 41 |
|
|
2024
Q3 | $2.09M | Hold |
200,000
| – | – | 0.63% | 38 |
|
|
2024
Q2 | $2.04M | Hold |
200,000
| – | – | 0.6% | 39 |
|
|
2024
Q1 | $2.08M | Buy |
+200,000
| New | +$2.08M | 0.55% | 36 |
|